Nuzenio

Class Bispecific Adc

Class Bispecific Adc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Promatix secures Innovate UK grant to advance cis-bispecific ADC programme - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:14:55 GMT Pathos AI Enters Global Licensing Agreement with Alphamab Oncology on JSKN016, a First-in-Class TROP2/HER3 Bispecific ADC - Business WireBusiness Wire · Tue, 04 Aug 2026 00:00:00 GMT Promatix Biosciences Awarded Innovate UK Biomedical - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 07:30:00 GMT New Iza-bren Approvals Underscore China's Rising Role In Bispecific ADCs - SahmSahm · Tue, 28 Jul 2026 07:00:00 GMT VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb - The Manila TimesThe Manila Times · Mon, 27 Jul 2026 11:17:21 GMT Veraxa Advances Bispecific ADC Candidate VXA-222 Following OmniAb Discovery Milestone - BioPharm InternationalBioPharm International · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Tue, 04 Aug 2026 12:14:55 GMTPromatix secures Innovate UK grant to advance cis-bispecific ADC programme - Manufacturing Chemist

Tue, 04 Aug 2026 00:00:00 GMTPathos AI Enters Global Licensing Agreement with Alphamab Oncology on JSKN016, a First-in-Class TROP2/HER3 Bispecific ADC - Business Wire

Tue, 28 Jul 2026 07:30:00 GMTPromatix Biosciences Awarded Innovate UK Biomedical - GlobeNewswire

Tue, 28 Jul 2026 07:00:00 GMTNew Iza-bren Approvals Underscore China's Rising Role In Bispecific ADCs - Sahm

Mon, 27 Jul 2026 11:17:21 GMTVERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb - The Manila Times

Mon, 27 Jul 2026 07:00:00 GMTVeraxa Advances Bispecific ADC Candidate VXA-222 Following OmniAb Discovery Milestone - BioPharm International

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Innovate UK2 live mentions ADC2 live mentions Alphamab Oncology2 live mentions First2 live mentions Class2 live mentions Approvals Underscore China2 live mentions Rising Role In2 live mentions VERAXA Biotech Announces2 live mentions Advancement2 live mentions Novel Bispecific Antibody2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Class Bispecific Adc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.